CRBU
Caribou Biosciences Inc
0.4602$
-4.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 508.0% | 89.4% | 515.9% | 1,222.0% | 640.9% | 835.2% | 398.1% | 10.7% | 522.7% | 538.6% | 32.5% | 697.1% | 734.1% | 705.8% | 120.8% | 55.5% | 29.2% | 24.7% | 1,473.4% | 1,437.8% | 74.1% | 48.7% | 1,019.2% | 17.3% | 27.1% | – | – | |
| 100.0% | 100.0% | 100.0% | -1,122.0% | -540.9% | -735.2% | -298.1% | 89.3% | -422.7% | -438.6% | 100.0% | -597.1% | -634.1% | -605.8% | -20.8% | 44.5% | 70.8% | 75.3% | -1,373.4% | -1,337.8% | 25.9% | 51.3% | -919.2% | 100.0% | 72.9% | 100.0% | -129.7% | |
| 508.0% | 89.4% | 515.9% | 1,540.4% | 640.9% | 835.2% | 398.1% | 590.5% | 522.7% | 538.6% | 605.2% | 713.3% | 734.1% | 705.8% | 120.8% | 879.1% | 1,391.0% | 1,024.2% | 1,503.0% | 1,466.7% | 1,510.0% | 1,038.3% | 1,019.2% | 604.3% | 859.9% | 1,263.6% | 854.7% | |
| 205.1% | 37.2% | 271.0% | 424.1% | 289.8% | 346.4% | 170.0% | 306.9% | 360.1% | 239.6% | 298.2% | 231.1% | 254.4% | 269.5% | 41.0% | 273.2% | 602.8% | 331.6% | 293.5% | 505.0% | 413.7% | 390.1% | 418.4% | 217.7% | 336.5% | 526.8% | 336.2% | |
| 713.1% | 126.6% | 786.9% | 424.1% | 289.8% | 346.4% | 170.0% | 886.7% | 360.1% | 239.6% | 903.4% | 231.1% | 254.4% | 269.5% | 41.0% | 1,096.9% | 1,964.6% | 1,331.1% | 515.9% | 533.8% | 1,849.7% | 1,835.3% | 418.4% | 822.0% | 1,169.3% | 1,790.4% | 961.2% | |
| -613.1% | -26.6% | -686.9% | -1,546.0% | -830.7% | -1,081.6% | -468.1% | -797.4% | -782.8% | -678.2% | -803.4% | -828.2% | -888.5% | -875.3% | -61.8% | -1,052.3% | -1,893.9% | -1,255.8% | -1,889.2% | -1,871.7% | -1,823.8% | -1,784.0% | -1,337.6% | -722.0% | -1,096.4% | -1,690.4% | -1,090.9% | |
| 0.2% | 0.1% | 0.5% | 0.6% | 0.3% | 0.1% | 0.6% | 0.6% | 3.3% | 0.4% | 0.9% | 111.2% | 87.7% | – | – | 86.3% | – | – | – | – | – | – | – | – | – | – | – | |
| -646.8% | -22.7% | -680.0% | -1,530.2% | -829.7% | -969.6% | -527.4% | -709.6% | -716.5% | -636.9% | -806.8% | -729.1% | -800.8% | -786.1% | -42.3% | -964.4% | -1,697.6% | -1,088.3% | -1,713.6% | -1,709.1% | -1,699.6% | -2,028.4% | -1,253.3% | -686.1% | -1,046.5% | -1,619.9% | -1,035.9% | |
| -70.7% | -0.6% | -17.8% | -36.0% | 1.4% | 1.8% | -59.8% | 12.5% | -66.3% | -41.4% | 3.3% | 1.9% | -87.3% | -17.0% | -12.9% | 5.4% | -29.2% | – | – | -0.4% | – | – | – | -14.0% | – | – | – | |
| -576.1% | -22.1% | -662.2% | -1,494.2% | -829.7% | -969.6% | -527.4% | -722.1% | -716.5% | -636.9% | -806.8% | -731.0% | -800.8% | -786.1% | -42.3% | -969.8% | -1,697.6% | -1,088.3% | -1,713.6% | -1,708.7% | -1,699.6% | -2,028.4% | -1,253.3% | -672.1% | -1,046.5% | -1,619.9% | -1,030.4% | |
| -633.3% | -19.9% | -660.6% | -1,507.2% | -816.8% | -953.9% | -520.8% | -698.9% | -705.0% | -628.3% | -793.1% | -715.4% | -784.0% | -769.7% | -35.6% | -943.6% | -1,668.3% | -1,063.5% | -1,655.5% | -1,785.8% | -1,650.1% | -1,284.6% | -1,224.6% | -668.8% | -1,019.4% | -1,760.9% | -1,037.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.